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2. Background
Hyperactivity in children is characterized by inattention, impulsivity and overactivity. In addition, 
Artificial food colors (AFCs) and other food additives have an adverse effect on children with 
ADHD.1 There is less clear evidence for the adverse effect of AFCs on behavior in children in the 
general population. A previous study using double blind controlled challenges conducted by us on 
the Isle of Wight has suggested an adverse effect of AFCs on the behaviour of 3 year old children.2
We have shown that mixtures of some food colours and a sodium benzoate preservative can 
increase the level of hyperactivity in children from the general population.3 These results came 
from a double-blind placebo controlled cross-over trial of two additive mixes administered in doses 
equivalent to the daily average intake for a child population : 
Mix A  – sunset yellow (E110), carmoisine (E122), tartrazine (E102),   ponceau 4R(E124) and sodium benzoate (E211).
Mix B  – sunset yellow (E110), carmoisine (E122), quinoline yellow (E104), allura red AC(E129)) and sodium benzoate(E211). 
Figure 1 illustrates the elevation of hyperactivity levels for 3yos (n=153) and for 8/9yos (n= 144).
3. Genetic moderation of the effect of food additives
DNA was extracted from buccal cells in these children and genotyped for two  histamine N-mtheyltransferse
single neucleotide polymorphisms (SNPs) in the histamine N-methyltranferase gene, Thr105Ile (rs1801105) 
and T939C (rs1050891), for one SNP in the dopamine gene, catechol-o-methyltransferase (COMT Val108Met, 
rs4680), and one SNP in the adrenergic neurotransmitter system, adrenergic receptor alpha 2A (ADRA2A 
C1291G, rs1800544). 
The key question : 
do these SNPs show an interaction with the effect of food challenge.
Fig. 2 shows that for 8/9yo children a moderating effect of the 939C present genotype was found which 
significantly reduced the adverse effect of Mix A (p=.021) (difference in pink) and of Mix B (p=.026) 
(difference in green). A similar effect for 105Ile present genotype for Mix B with 3yos. fell just short of 
significance (p=.061).  The 105Ile present genotype moderated the effect of Mix A in 3 yos. (p=.041) but not for 
8/9-yos. The COMT Val108Met and ADRA2A C1291G polymorphisms did not show any moderating effect at 
either age 3 or 8/9-years of age for either Mix.
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4. Conclusions
▪ there is a link between histamine and hyperactivity  ▪ polymorphisms in the HNMT gene moderate behavioural responses to AFCs
▪ HNMT polymorphisms impair histamine clearance4  ▪ an AFC challenge causes histamine release5 
▪ H3 receptors in the brain provide a potential mechanism for  the effect6  ▪many environmental factors will increase histamine release, e.g. infections and food.
▪ is this why food allergy/intolerance is suggested to be  a cause of hyperactivity?  ▪ doe this explain the effects of infections in aggravating behavior?
▪ current focus on dopamine in studies of ADHD needs to be extended.  ▪ such gene x environment interactions may contribute to effects on ADHD
▪ this proposed mechanism  clearly indicates a potential target for therapeutic intervention in ADHD focused on the H3 receptor.
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Fig. 2 Moderation of the effect of additive 
mixes on hyperactivity in 8/9 year olds
1. Abstract
Introduction: The claim of a relationship between artificial food color and additive (AFCs) intake and behavior is highly 
contentious. We have shown in a previous population-based trial with 3yo children adverse effects of food additives on 
parentally-rated hyperactive behaviour (Bateman et al, 2004). The possible role of genetic polymorphisms in moderating this 
adverse effect has not been previously examined. Methods A randomised, double blind, placebo-controlled, within subject 
crossover food challenge was used for 144, 8 to 9 year old children and 153, 3 year old children.  Following baseline 
assessment children were placed on a diet eliminating food additives and a benzoate preservative for 6 weeks during which 
time they were challenged for weekly periods with either a placebo mix or a drink containing sodium benzoate (45mg daily) and 
one of two mixes of AFCs.: Results: The T939C and Thr105Ile polymorphisms of the histamine N-methyltransferase gene 
(HNMT) moderated the adverse  effect s of AFCs but the polymorphisms in catecholamine genes COMT Val108Met and
ADRA2A C1291G did not. These findings point to a possible role for histamine in mediating the effects of food additives and 
help to explain why there has been inconsistency between previous studies.  Conclusions: Genes influencing a range of 
neurotransmitter systems and their interplay with environmental factors, such as diet, need to be examined to understand 
genetic influences on hyperactivity.
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Fig.1 Effect of additive mixes on hyperactivity